Charles Riv­er Lab­o­ra­to­ries snaps up Cog­nate for a cool $875M, looks to ex­pand cell and gene ther­a­py CD­MO foothold

With the cell and gene ther­a­py space as hot as ever, big-name CD­MO Charles Riv­er Lab­o­ra­to­ries is look­ing to carve out a big piece of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.